Загрузка...
Udenafil: efficacy and tolerability in the management of erectile dysfunction
Udenafil is a potent novel phosphodiesterase-5 inhibitor approved for use in Korea. Udenafil has unique properties, with a T (max) of 1.0–1.5 h and a T (1/2) of 11–13 h (a relatively rapid onset and a long duration of action). Therefore, both on-demand and once-daily use of udenafil have been report...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3607490/ https://ncbi.nlm.nih.gov/pubmed/23554845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287212470019 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|